share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Duker Jay S.
美股sec公告 ·  07/12 17:08
Moomoo AI 已提取核心訊息
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals總裁兼首席執行官Jay S. Duker於2024年7月10日完成了一項股票交易。Duker行使期權以免費獲得16,666股普通股,並隨後以每股8.69美元的價格出售了8,059股股票。已售出股票的總市值爲70,032.71美元。在這些交易之後,Duker直接持有EyePoint Pharmaceuticals的38,027股股票。此外,一家家庭信託保留了22,500股間接持股。
EyePoint Pharmaceuticals總裁兼首席執行官Jay S. Duker於2024年7月10日完成了一項股票交易。Duker行使期權以免費獲得16,666股普通股,並隨後以每股8.69美元的價格出售了8,059股股票。已售出股票的總市值爲70,032.71美元。在這些交易之後,Duker直接持有EyePoint Pharmaceuticals的38,027股股票。此外,一家家庭信託保留了22,500股間接持股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息